Atlas Trials

Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease

Clinical trial NCT02055274 · COMPLETED

Trial details

NCT number
NCT02055274
Sponsor
Luye Pharma Group Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2013-10-01
Primary completion
2015-08-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.